shouldiuse.io

Categories

VERDICT

Should I use Neogenomics?

NeoLINK Login - neogenomics.com

Depends. NeoGenomics is a publicly traded cancer-diagnostics lab, not software — oncology practices, hospitals, and pharma needing specialty testing are the fit. Anyone expecting a SaaS tool, published pricing, or free trial should not buy.

Confidence

Medium. Based on 16 public sources; mostly employee reviews, filings, and news — buyer-side review data is thin.

Ratings

  • Value for money
  • Ease of useNo product-UX evidence found
  • Feature depth
  • Support qualityOnly truncated anecdotes; no support data
  • Security posture

Pricing

Not disclosed

ModelNot disclosed
Monthly feesNot disclosed
HardwareNot disclosed

Best for

  • Oncology practices needing specialty pathology
  • Pharma and biotech trial testing
  • Hospitals outsourcing complex cancer diagnostics

Not for

  • Anyone shopping for software — this is a lab, not a SaaS tool
  • Small clinics with routine lab needs — Labcorp/Quest are simpler
  • Self-serve buyers — no pricing, trials, or signup
  • Teams wanting peer reviews — zero G2 reviews exist

Gotchas - check before you buy

medium

No published prices — billing runs through insurance and negotiated client contracts; expect opaque invoices

medium

$9.8M False Claims Act settlement (July 2026) over compensation arrangements — compliance yellow flag

medium

G2 shows zero product reviews — request references before committing

low

Past securities class actions (filed 2022; dismissed March 2026) signal investor-relations turbulence

Pros and cons

Pros

  • Publicly traded specialty oncology lab; ~$190M quarterly revenue
  • Broad menu: pathology, molecular, liquid biopsy, pharma services, informatics tools
  • Enterprise security stack: CyberArk privileged-access management, dedicated security engineers
  • Holds a U.S. Department of Veterans Affairs contract

Cons

  • Zero G2 reviews — no buyer-side feedback to vet
  • Not software: no pricing page, tiers, trials, or self-serve signup
  • Employee reviews mixed; 'poor work/life balance' flagged at Fort Myers
  • Paid $9.8M False Claims Act settlement over compensation arrangements

Sources & method

Analyzed 10/06/2026 - 16 sources - No known vulnerabilities found in the sources reviewed.

official x4review x6security x3news x3

Key stats

  • Value for money: 2/5

    Rating

  • Not disclosed

    Starting price

  • 16

    Sources

  • Analyzed

  • Value for money: 2/5. No public pricing; insurance-billed; FCA settlement
  • Ease of use. No product-UX evidence found
  • Feature depth: 4/5. Broad specialty oncology menu plus pharma services
  • Support quality. Only truncated anecdotes; no support data
  • Security posture: 4/5. Enterprise CyberArk PAM; dedicated security hires; no breaches
  • 58% Glassdoor 'would recommend' 498 employee reviews
  • 0 G2 product reviews NeoGenomics Laboratories products
  • ~$190M Quarterly revenue Q4, company-reported
  • $9.8M False Claims Act settlement DOJ/OIG, July 2026

Pricing

Not disclosed

Security

No known vulnerabilities found in the sources reviewed.

What users say

Evidence is mostly employee-side — 498 Glassdoor and 178 Indeed reviews with mixed sentiment — plus sparse Reddit threads on second-opinion processes.

Companies that use it

  • U.S. Department of Veterans Affairs12
  • Eli Lilly
Full analysis

Based on 16 public sources; mostly employee reviews, filings, and news — buyer-side review data is thin.

Not software: a public cancer-diagnostics lab. Fits oncology/pharma testing buyers; no pricing, trials, or reviews.

Methodology

Based on 16 public sources; mostly employee reviews, filings, and news — buyer-side review data is thin.

Sources

  1. NeoGenomics Reviews (498) — Glassdoorglassdoor.com
    review
  2. Working at NeoGenomics: 178 Reviews — Indeedindeed.com
    review
  3. NeoGenomics Laboratories Products — G2 (0 reviews)g2.com
    review
  4. NeoGenomics Reviews in Fort Myers, FL — Indeedindeed.com
    review
  5. Should we be more aggressive in limiting Labcorp/Quest — Reddit r/pathologyreddit.com
    review
  6. Second Opinion Experiences — Reddit r/MPNreddit.com
    review
  7. Florida Laboratory Agrees to Pay $9.8M — HHS OIGoig.hhs.gov
    news
  8. NeoGenomics Beats Investor Suit Over Growth Driver Claims — Law360law360.com
    news
  9. NeoGenomics sees Q4 revenue of about $190M — MSNmsn.com
    news
  10. NeoGenomics Reports Second Quarter 2026 Results — IRir.neogenomics.com
    official
  11. NeoGenomics and Inivata to present at ESMO 2022 — IRir.neogenomics.com
    official
  12. VA contract award to NeoGenomics Laboratories — USAspendingusaspending.gov
    official
  13. NeoGenomics Billing pageneogenomics.com
    official
  14. SSL Server Test: flosum.neogenomics.comssllabs.com
    security
  15. SSL Server Test: neogenomics.privilegecloud.cyberark.comssllabs.com
    security
  16. Information Security Engineer job — NeoGenomicsziprecruiter.com
    security

Rate this review

Anonymous. You can change your vote.

Loading votes…

Comments

One queue. No nested comments. Give a display name first. Limit: 200 words per comment and 7 comments per day. You can edit or delete yours.

Save a name to write a comment.

0 / 200 words

No comments yet.